Grace Therapeutics
GRCE
10 hedge funds and large institutions have $1.05M invested in Grace Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
35% more capital invested
Capital invested by funds: $784K → $1.05M (+$271K)
25% more funds holding
Funds holding: 8 → 10 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$45K |
| 2 |
Renaissance Technologies
New York
|
+$6.96K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.63K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$370 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$888 |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$740 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $414K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $317K | – | – | – |
|
|
IIM
3
Intact Investment Management
Montreal,
Quebec, Canada
| $206K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $63K | +$6.96K | +94 | +15% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $52K | +$45K | +608 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $2K | +$1.63K | +22 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1K | +$370 | +5 | +63% |
|
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$888 | -12 | -92% |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$740 | -10 | -83% |
|
GRCE Hedge Fund Activity: Q3 2016 in Review
10 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q3 2016, worth a combined $1.05M — up 35% from $784K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GRCE positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $45K. The largest seller was Toronto Dominion Bank, cutting an estimated $888.
- 10 institutional investors held Grace Therapeutics (GRCE) as of Q3 2016, up from 8 in Q2 2016.
- Funds reported $1.05M of Grace Therapeutics stock for Q3 2016, up 35% quarter-over-quarter.
- 2 funds opened new Grace Therapeutics positions in Q3 2016 and 0 closed out, a net change of +2 holders.
- The largest Grace Therapeutics buyer in Q3 2016 was Virtu KCG Holdings, an estimated $45K added.
- The largest Grace Therapeutics seller in Q3 2016 was Toronto Dominion Bank, an estimated $888 sold.
Based on aggregated 13F filings for Q3 2016.